scispace - formally typeset
F

Freddie Bray

Researcher at International Agency for Research on Cancer

Publications -  452
Citations -  345102

Freddie Bray is an academic researcher from International Agency for Research on Cancer. The author has contributed to research in topics: Cancer & Population. The author has an hindex of 111, co-authored 402 publications receiving 262938 citations. Previous affiliations of Freddie Bray include University of Oslo.

Papers
More filters
Journal ArticleDOI

Planning for tomorrow: global cancer incidence and the role of prevention 2020-2070.

TL;DR: In this article, the authors assess studies modelling the future burden of cancer that underscore how comprehensive cancer prevention strategies can markedly reduce the prevalence of major risk factors and, in so doing, the number of future cancer cases.
Journal ArticleDOI

Thyroid cancer incidence trends by histology in 25 countries: a population-based study.

TL;DR: In this paper, the authors presented an overview of international trends of thyroid cancer incidence by major histological subtypes, and calculated age-specific incidence rates and age-standardised rates per 100,000 person-years for individuals aged 20 to 84 years.
Journal ArticleDOI

50 years of screening in the Nordic countries: quantifying the effects on cervical cancer incidence

TL;DR: According to extrapolations from cohort effects, cervical cancer incidence rates in the Nordic countries would have been otherwise comparable to the highest incidence rates currently detected in low-income countries.
Journal ArticleDOI

The global cancer burden and human development: A review:

TL;DR: There remain clear disparities in the cancer burden according to national Human Development Index scores, and international efforts are needed to aid countries in social and economic transition to reduce the widening gap in cancer occurrence and survival worldwide.
Journal ArticleDOI

Clinical Relevance of Conditional Survival of Cancer Patients in Europe: Age-Specific Analyses of 13 Cancers

TL;DR: Conditional 5-year relative survival shows clinically relevant variations according to time since diagnosis, type of cancer, and age, and can help serve as a guide for cancer survivors in planning for their future and for doctors in planning schedules for surveillance.